| Crinetics Pharmaceuticals, Inc. | 2,675 | US$223K | 2.6% |
| Mbx Biosciences, Inc. | 2,963 | US$195K | 2.3% |
| Ataibeckley Inc. | 24,288 | US$174K | 2.0% |
| Definium Therapeutics, Inc. | 3,950 | US$172K | 2.0% |
| Amylyx Pharmaceuticals, Inc. | 6,821 | US$139K | 1.6% |
| Enliven Therapeutics, Inc. | 2,481 | US$136K | 1.6% |
| Corcept Therapeutics Incorporated | 1,175 | US$135K | 1.6% |
| Alumis Inc. | 4,577 | US$129K | 1.5% |
| Nuvation Bio Inc. | 20,045 | US$127K | 1.5% |
| Trevi Therapeutics, Inc. | 6,851 | US$125K | 1.5% |
| Liquidia Corporation | 1,407 | US$118K | 1.4% |
| Nektar Therapeutics | 1,617 | US$114K | 1.3% |
| Amneal Pharmaceuticals, Inc. | 5,993 | US$110K | 1.3% |
| Bristol-myers Squibb Company | 1,651 | US$108K | 1.3% |
| Edgewise Therapeutics, Inc. | 2,789 | US$107K | 1.2% |
| Omeros Corporation | 9,001 | US$107K | 1.2% |
| Ligand Pharmaceuticals Incorporated | 370 | US$106K | 1.2% |
| Elanco Animal Health Incorporated | 4,014 | US$106K | 1.2% |
| Veradermics, Incorporated | 987 | US$104K | 1.2% |
| Pacira Biosciences, Inc. | 3,920 | US$104K | 1.2% |
| Viatris Inc. | 5,822 | US$102K | 1.2% |
| Jazz Pharmaceuticals Plc | 400 | US$101K | 1.2% |
| Eton Pharmaceuticals, Inc. | 2,169 | US$101K | 1.2% |
| Maze Therapeutics, Inc. | 3,733 | US$100K | 1.2% |
| Merck & Company, Inc. | 771 | US$100K | 1.2% |
| Harrow, Inc. | 2,557 | US$99,135 | 1.2% |
| Johnson & Johnson | 385 | US$98,695 | 1.2% |
| Royalty Pharma Plc | 1,684 | US$98,396 | 1.1% |
| Indivior Pharmaceuticals, Inc. | 2,410 | US$96,424 | 1.1% |
| Prestige Consumer Healthcare Inc. | 1,869 | US$93,861 | 1.1% |
| Collegium Pharmaceutical, Inc. | 2,638 | US$93,359 | 1.1% |
| Eli Lilly And Company | 81 | US$93,056 | 1.1% |
| Organon & Co. | 6,862 | US$92,980 | 1.1% |
| Eyepoint, Inc. | 7,446 | US$91,214 | 1.1% |
| Harmony Biosciences Holdings, Inc. | 2,588 | US$91,201 | 1.1% |
| Supernus Pharmaceuticals, Inc. | 2,036 | US$90,867 | 1.1% |
| Pfizer, Inc. | 3,586 | US$89,686 | 1.0% |
| Wave Life Sciences Ltd. | 16,221 | US$89,378 | 1.0% |
| Phibro Animal Health Corporation | 2,460 | US$89,372 | 1.0% |
| Ani Pharmaceuticals, Inc. | 1,122 | US$88,907 | 1.0% |
| Tarsus Pharmaceuticals, Inc. | 1,498 | US$88,442 | 1.0% |
| Zoetis Inc. | 1,129 | US$87,260 | 1.0% |
| Ocular Therapeutix, Inc. | 10,504 | US$85,818 | 1.0% |
| Xeris Biopharma Holdings, Inc. | 10,572 | US$85,422 | 1.00% |
| Rapport Therapeutics, Inc. | 2,076 | US$85,074 | 0.99% |
| Innoviva, Inc. | 3,992 | US$83,712 | 0.98% |
| Perrigo Company Plc | 8,219 | US$83,094 | 0.97% |
| Axsome Therapeutics, Inc. | 373 | US$81,310 | 0.95% |
| Amphastar Pharmaceuticals, Inc. | 3,730 | US$74,376 | 0.87% |
| Arvinas, Inc. | 9,028 | US$72,495 | 0.85% |
| Alto Neuroscience, Inc. | 2,671 | US$72,304 | 0.84% |
| Septerna, Inc. | 1,779 | US$61,287 | 0.71% |
| Lb Pharmaceuticals Inc | 1,477 | US$59,198 | 0.69% |
| Cormedix Inc. | 7,721 | US$58,139 | 0.68% |
| Theravance Biopharma, Inc. | 3,386 | US$57,088 | 0.67% |
| Aclaris Therapeutics, Inc. | 10,166 | US$52,863 | 0.62% |
| Phathom Pharmaceuticals, Inc. | 5,895 | US$51,581 | 0.60% |
| Zevra Therapeutics, Inc. | 5,187 | US$49,328 | 0.58% |
| Relmada Therapeutics, Inc. | 9,199 | US$48,847 | 0.57% |
| Aquestive Therapeutics, Inc. | 11,061 | US$40,870 | 0.48% |
| Fulcrum Therapeutics, Inc. | 11,341 | US$40,601 | 0.47% |
| Lexicon Pharmaceuticals, Inc. | 15,756 | US$36,396 | 0.42% |
| Bioage Labs, Inc. | 3,681 | US$33,276 | 0.39% |
| Evolus, Inc. Common Stock | 4,569 | US$26,683 | 0.31% |
| Esperion Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |